Publications
Explore our research contributions in vaccine development, clinical trials, and therapeutic studies published in leading scientific journals.
Vaccine Studies
Thuluva, S. et al. (2023)
Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a Phase-3, single blind, multicentre, randomized clinical trial.
Human Vaccines & Immunotherapeutics, Vol. 19, Issue 1
Thuluva, S. et al. (2022)
Safety, tolerability and immunogenicity of Biological E's CORBEVAX™ vaccine in children and adolescents: A prospective, randomised, double-blind, placebo controlled, phase-2/3 study.
Vaccine, Vol. 40, Issue 49, pp. 7130–7140
MedRxiv (2022)
Selection of optimum formulation of RBD-based protein sub-unit covid19 vaccine (Corbevax) based on safety and immunogenicity in an open-label, randomized Phase-1 and 2 clinical trial.
MedRxiv, 2022.03.08.22271822
Dang, A. et al. (2025)
Transforming Allergy Care in India: The Role of Component Resolved Diagnostic Panels in Enhancing Personalization and Cost-Effectiveness.
Journal of Allergy and Clinical Immunology, 155(2), AB70
Singh, J. et al. (2023)
Is a negative COVID-19 RT-PCR enough to rule out COVID-19? – A case series examining the limitations of PCR testing in clinical diagnosis.
Medical Research Archives, 11(12)
Drug / Therapeutic Studies
Povidone Iodine Spray Study (2024)
Two pilots randomized controlled trial evaluating Povidone iodine (Betadine) spray for upper respiratory tract infections.
International Journal of Emerging Technologies and Innovative Research, Vol. 11, Issue 7
Dhabhai, N. et al. (2023)
Burden, risk factors and outcomes associated with adequately treated hypothyroidism in a population-based cohort of pregnant women from North India.
PLOS ONE, Vol. 18, Issue 9
Dhabhai, N. et al. (2022)
Prevalence of reproductive tract infections including sexually transmitted infections among married women in urban and peri-urban mid to low socioeconomic neighbourhoods of Delhi, North India.
BMJ Open, Vol. 12, Issue 3
Bedi, N. et al. (2021)
Transplacental COVID Antibodies and Cytokine Storm in Newborn: Presence of Antibodies does not Indicate Protection Always!
The Journal of the Association of Physicians of India, 69(1), 76-77
Chandra, K. et al. (2023)
Phenotyping of lymphocyte subsets, Th-1/Th-2 cytokines and other parameters in high-risk contacts of SARS-CoV-2.
Indian Journal of Pathology and Microbiology, 66(4), 732-739
Dang, A. et al. (2020)
Covid-19 Drive Through Testing - A Novel, Scalable, High-Throughput and Safe Sampling Model in the Covid-19 Pandemic.
Clinical Research Publication
Marwaha, R.K. et al. (2019)
A randomised controlled trial comparing the efficacy of micellised and fat-soluble vitamin D3 supplementation in healthy adults.
British Journal of Nutrition, Vol. 121, Issue 8, pp. 859-865
Dhabhai, N. et al. (2025)
Prevalence of reproductive tract and sexually transmitted infections among symptomatic and asymptomatic women, validity of syndromic management, in urban and periurban low to mid socioeconomic neighbourhoods of North Delhi.
BMJ Public Health, 3:e001791
Ella, R. et al. (2021)
Safety and Immunogenicity of an Inactivated SARS-CoV-2 Vaccine (BBV152) - comprehensive evaluation of vaccine safety profile and immune response.
The Lancet Infectious Diseases, Volume 21, Issue 7, Pages 950–961
Smith, E.R. et al. (2024)
Protocol for the Redefining Maternal Anemia in Pregnancy and Postpartum (ReMAPP) Study - establishing new diagnostic criteria.
PLOS ONE, 20(7): e0321943
